A study published in NEJM May 2019, Controlled Trial of Budesonide-Formoterol as Needed for Mild Asthma, contributed to a major change in the Global Initiative of Asthma (GINA) recommendations. Brief Study Overview This was a 52-week, randomized, open-label, parallel-group, controlled trial which was conducted at 16 trial centers in New Zealand, UK, Italy and Australia.It … Continue reading How are we managing Asthma in 2019? →